HSD17B13-IN-38
HSD17B13-IN-38 (Compound D) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) . HSD17B13-IN-38 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH[1].
Product Specifications
CAS Number
2730022-56-5
UNSPSC
12352005
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-38.html
Solubility
10 mM in DMSO
Smiles
CCOC(C1=CC=CC(N2C(C3=CC=NC=C3)=NC4=C2C=CC(OC)=C4)=C1)=O
Molecular Formula
C22H19N3O3
Molecular Weight
373.40
References & Citations
[1]Vincent FLORIO, et al. Substrate selective hsd17b13 inhibitors and uses thereof. WIPO, WO2021211981A1. 2021-10-21.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH031484 20 µg
Recombinant Human Carbonic Anhydrase 10/CA10 Protein
Sign In for Pricing
View Details 
BNC042348-100 1x 100 µL
Neurofilament (NF-H) (Neuronal Marker) (rNF421), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 